CJC-1295 (No DAC) is a synthetic growth hormone-releasing hormone analogue designed to mimic the biologically active region of endogenous GHRH without drug affinity complex modification. It has been studied in growth-axis research for its relationship to pulsatile growth hormone release, IGF-1 signaling behavior, and recovery-associated endocrine pathways in controlled peptide models. Its shorter-acting profile preserves a more transient signaling pattern compared to DAC-modified variants. Lyophilized powder, 3mL vial. Sold at 10mg per vial. For research use only.